Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 4/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL27879925 | 0.93 | ALDH1A1 (0.71) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL2058931 | 0.93 | ALDH1A1 (0.71) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL132792 | 0.93 | ALDH1A1 (0.71) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL1393768 | 0.93 | ALDH1A1 (0.71) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL6856289 | 0.91 | ALDH1A1 (0.68) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL16972970 | 0.91 | ALDH1A1 (0.68) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL8470012 | 0.91 | ALDH1A1 (0.68) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL28474613 | 0.91 | ALDH1A1 (0.68) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL8056537 | 0.91 | ALDH1A1 (0.68) | ALDH1A1LMNAKDM4ECYP2D6MEN1 | |
| Citric Acid SCHEMBL27822858 | 0.91 | ALDH1A1 (0.68) | ALDH1A1LMNAKDM4ECYP2D6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120028936-A1 | ORAL CONTRACEPTION WITH TRIMEGESTONE | GRUNENTHAL GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20100279989-A1 | ORAL CONTRACEPTION WITH TRIMEGESTONE | Grünenthal GmbH (DE) | 2010-11-04 | — | — | US | disclosed |
| US-20090093448-A1 | 19-NOR-PROGESTERONE FOR CONTRACEPTION | GRUNENTHAL GMBH (DE) | 2009-04-09 | — | — | US | disclosed |
| US-20070021396-A1 | Oral contraception with trimegestone | GRUNENTHAL GMBH (DE) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093448-A1 | 19-NOR-PROGESTERONE FOR CONTRACEPTION | CYP19A1, CYP17A1, HSD17B11 | MEN1 1426/4885ALDH1A1 395/4885LMNA 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.